Endpoints News
China's BrightGene looks to the West Read in browser
Endpoints News
Thank you for reading, dupa dupackia!
basic
UPGRADE
M T W Thu F
2 July, 2026
SPOTLIGHT
Nominations are open for the 2026 Endpoints 11 awards — submit by July 15
ENDPOINTS NEWS
news
Roche’s lung cancer pill beats rivals in head-to-head Phase 3 study 
ENDPOINTS NEWS
BrightGene looks to the West as obesity shot nears China approval
ENDPOINTS NEWS
Peer Review
Ex-iTeos CEO starts fresh at GSK neuro partner; Genentech loses yet another key scientist
ENDPOINTS NEWS
Endpoints webinars
Jul 30
1:00 pm ET
Accelerating Phase 1 decisions with liquid biopsy: From early signals to actionable insights
GUARDANT
Manufacturing Day 2026
Biopharma has metabolized the tariff chaos, but the ground keeps shifting under manufacturing and supply chain teams. Hear directly from the experts on what’s changed, what’s working, and what to watch. Join us.
PHARMA
Merck scraps a Phase 2 Alzheimer's asset from partner Neuphoria
ENDPOINTS NEWS
As customers 'suspend relationships,' WuXi AppTec seeks injunction over China military list
ENDPOINTS NEWS
FDA warns Genzyme's Irish site over quality questions
ENDPOINTS NEWS
in case you missed it
1.
FDA approves Orca Bio’s cell therapy to improve transplant outcomes
ENDPOINTS NEWS
2.
BridgeBio adds $1B as it prepares three more drug launches
ENDPOINTS NEWS
3.
A discarded Amgen T cell engager comes back to life at its California creator, 92Bio
ENDPOINTS NEWS
4.
Ipsen to scoop up Memo Therapeutics and its kidney infection drug
ENDPOINTS NEWS
5.
News Briefing
Angitia ends Phase 3 in disc disease; Abivax targets $800M on colitis data
ENDPOINTS NEWS
6.
A June flourish lifts biotech megaround tally in first half of 2026
ENDPOINTS NEWS
7.
Updated: Anthropic launches Claude Science as a product for biopharma, starts own drug programs
ENDPOINTS NEWS
8.
US-UK drug deal could result in 229,000 excess deaths in England, analysis suggests
THE GUARDIAN
9.
This cell feeds, grows and reproduces. And it’s manmade.
THE NEW YORK TIMES
Elizabeth Cairns
.

Tomorrow is a public holiday in the US to celebrate Independence Day, and the country's semiquincentennial at that. Endpoints won't be sending our usual newsletters, but we'll return on Monday, July 6. Have a great long weekend!

.
Elizabeth Cairns
Senior Biopharma Journalist, Endpoints News
Endpoints News